We are live on ! Find out more
WP

Woodline Partners Portfolio holdings

AUM $26.4B
1-Year Est. Return 44.85%
This Fund
S&P 500
This Quarter Est. Return
-10.21%
1 Year Est. Return
+44.85%
3 Year Est. Return
+131.23%
5 Year Est. Return
+174.12%
10 Year Est. Return
AUM
$6.49B
AUM Growth
+$329M
Cap. Flow
+$1.05B
Cap. Flow %
16.14%
Top 10 Hldgs %
17.7%
Holding
945
New
236
Increased
167
Reduced
92
Closed
153

Top Buys

Rank Stock Value
1
LLY icon
Eli Lilly
LLY
+$112M
2
SWKS icon
Skyworks Solutions
SWKS
+$103M
3
STM icon
STMicroelectronics
STM
+$87.3M
4
ASML icon
ASML
ASML
+$71.6M
5
PANW icon
Palo Alto Networks
PANW
+$64.4M

Sector Composition

Rank Sector Weight
1 Healthcare 34.94%
2 Technology 31.31%
3 Financials 8.29%
4 Industrials 7.52%
5 Communication Services 4.71%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
SGEN
26
DELISTED
Seagen Inc. Common Stock
SGEN
$41.3M 0.64%
233,620
-1,174,073
-83% -$169M
GOOGL icon
27
Alphabet (Google) Class A
GOOGL
$4.12T
$39.7M 0.61%
363,920
-120,960
-25% -$14.2M
ISRG icon
28
Intuitive Surgical
ISRG
$127B
$39.2M 0.6%
+195,324
New +$45.8M
ESTC icon
29
Elastic
ESTC
$6.7B
$38.9M 0.6%
+574,859
New +$41.9M
AVTR icon
30
Avantor
AVTR
$9.73B
$38.2M 0.59%
+1,226,844
New +$38.3M
NATI
31
DELISTED
National Instruments Corp
NATI
$37.5M 0.58%
1,199,238
+312,042
+35% +$11.1M
LHX icon
32
L3Harris
LHX
$55.4B
$35.8M 0.55%
148,223
-33,203
-18% -$8.01M
CRM icon
33
Salesforce
CRM
$154B
$35.5M 0.55%
+215,239
New +$38M
HUM icon
34
Humana
HUM
$43.9B
$34.8M 0.54%
74,251
-5,883
-7% -$2.62M
MRVL icon
35
Marvell Technology
MRVL
$147B
$34.5M 0.53%
791,839
+538,811
+213% +$30.5M
CL icon
36
Colgate-Palmolive
CL
$74.8B
$33.9M 0.52%
+423,486
New +$33.1M
ZEN
37
DELISTED
ZENDESK INC
ZEN
$33.8M 0.52%
+456,000
New +$45M
RXDX
38
DELISTED
Prometheus Biosciences, Inc. Common Stock
RXDX
$33.6M 0.52%
1,191,661
+741,403
+165% +$21.5M
BMRN icon
39
BioMarin Pharmaceuticals
BMRN
$11.9B
$33.4M 0.51%
+403,169
New +$32.1M
DT icon
40
Dynatrace
DT
$12.7B
$33.3M 0.51%
+844,775
New +$33.6M
PFE icon
41
Pfizer
PFE
$143B
$32.9M 0.51%
626,853
NXPI icon
42
NXP Semiconductors
NXPI
$60.8B
$32.9M 0.51%
+221,969
New +$38.6M
NUVA
43
DELISTED
NuVasive, Inc.
NUVA
$32.7M 0.5%
665,010
+336,741
+103% +$18.1M
ATVI
44
DELISTED
Activision Blizzard
ATVI
$32.5M 0.5%
418,002
+83,202
+25% +$6.47M
MCK icon
45
McKesson
MCK
$104B
$32.2M 0.5%
98,610
-31,372
-24% -$10M
SWCH
46
DELISTED
Switch, Inc. Class A Common Stock
SWCH
$31.8M 0.49%
+950,000
New +$30.7M
VMW
47
DELISTED
VMware, Inc
VMW
$31.4M 0.48%
275,426
+178,627
+185% +$20.3M
REGN icon
48
Regeneron Pharmaceuticals
REGN
$72.9B
$31.2M 0.48%
52,792
-52,702
-50% -$34.3M
SMTC icon
49
Semtech
SMTC
$9.65B
$30.9M 0.48%
562,009
+120,532
+27% +$7.27M
CACI icon
50
CACI
CACI
$10.8B
$30.9M 0.48%
109,628
+9,022
+9% +$2.51M

Similar funds

Woodline Partners's Q2 2022 Portfolio in Review

As of Q2 2022, Woodline Partners held 945 positions worth $6.49B, up 5.3% from $6.16B the previous quarter. Its ten largest holdings account for 18% of the portfolio.

Woodline Partners deployed $1.05B of net new capital in Q2 2022, opening 236 new positions and adding to 167 existing holdings. Its largest new stake was Skyworks Solutions: 955,660 shares worth $88.5M.

By sector, the portfolio is most concentrated in Healthcare at 35% of assets, down from 39% a quarter earlier, followed by Technology and Financials.

On the sell side, the largest reduction was Seagen Inc. Common Stock, an estimated $169M trimmed.

  • Woodline Partners's largest Q2 2022 buy was Skyworks Solutions: 955,660 shares worth $88.5M.
  • Woodline Partners added most to Eli Lilly in Q2 2022, an estimated $112M increase.
  • Woodline Partners's biggest Q2 2022 reduction was Seagen Inc. Common Stock, cutting an estimated $169M.
  • Woodline Partners fully exited Cooper Companies in Q2 2022, selling an estimated $103M.
  • Woodline Partners's ten largest holdings make up 18% of its $6.49B portfolio in Q2 2022.
  • Woodline Partners opened 236 new positions and closed 153 in Q2 2022.
  • Woodline Partners's portfolio value rose 5.3% quarter-over-quarter to $6.49B.

Based on Woodline Partners's 13F filing for Q2 2022, filed 15 Aug 2022.